Detalles de la búsqueda
1.
Risk of liver-related events in metabolic dysfunction-associated steatohepatitis (MASH) patients with fibrosis: A comparative analysis of various risk stratification criteria.
Hepatology
; 79(4): 912-925, 2024 Apr 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-37796137
2.
Global survey of stigma among physicians and patients with nonalcoholic fatty liver disease.
J Hepatol
; 80(3): 419-430, 2024 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-37984709
3.
Accuracy, Reliability, and Comprehensibility of ChatGPT-Generated Medical Responses for Patients With Nonalcoholic Fatty Liver Disease.
Clin Gastroenterol Hepatol
; 22(4): 886-889.e5, 2024 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-37716618
4.
Cenicriviroc Lacked Efficacy to Treat Liver Fibrosis in Nonalcoholic Steatohepatitis: AURORA Phase III Randomized Study.
Clin Gastroenterol Hepatol
; 22(1): 124-134.e1, 2024 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-37061109
5.
Enhanced diagnosis of advanced fibrosis and cirrhosis in individuals with NAFLD using FibroScan-based Agile scores.
J Hepatol
; 78(2): 247-259, 2023 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-36375686
6.
The Association of Histologic and Noninvasive Tests With Adverse Clinical and Patient-Reported Outcomes in Patients With Advanced Fibrosis Due to Nonalcoholic Steatohepatitis.
Gastroenterology
; 160(5): 1608-1619.e13, 2021 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-33307033
7.
Clinical Care Pathway for the Risk Stratification and Management of Patients With Nonalcoholic Fatty Liver Disease.
Gastroenterology
; 161(5): 1657-1669, 2021 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-34602251
8.
TVB-2640 (FASN Inhibitor) for the Treatment of Nonalcoholic Steatohepatitis: FASCINATE-1, a Randomized, Placebo-Controlled Phase 2a Trial.
Gastroenterology
; 161(5): 1475-1486, 2021 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-34310978
9.
A Global Survey of Physicians Knowledge About Nonalcoholic Fatty Liver Disease.
Clin Gastroenterol Hepatol
; 20(6): e1456-e1468, 2022 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-34229038
10.
Clinical and Patient-Reported Outcomes From Patients With Nonalcoholic Fatty Liver Disease Across the World: Data From the Global Non-Alcoholic Steatohepatitis (NASH)/ Non-Alcoholic Fatty Liver Disease (NAFLD) Registry.
Clin Gastroenterol Hepatol
; 20(10): 2296-2306.e6, 2022 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-34768009
11.
Liver stiffness measurement predicts short-term and long-term outcomes in patients with hepatocellular carcinoma after curative liver resection.
Surgeon
; 20(2): 78-84, 2022 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-33640283
12.
Monitoring Occurrence of Liver-Related Events and Survival by Transient Elastography in Patients With Nonalcoholic Fatty Liver Disease and Compensated Advanced Chronic Liver Disease.
Clin Gastroenterol Hepatol
; 19(4): 806-815.e5, 2021 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-32621970
13.
Association Between Fibrosis Stage and Outcomes of Patients With Nonalcoholic Fatty Liver Disease: A Systematic Review and Meta-Analysis.
Gastroenterology
; 158(6): 1611-1625.e12, 2020 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-32027911
14.
A new definition for metabolic dysfunction-associated fatty liver disease: An international expert consensus statement.
J Hepatol
; 73(1): 202-209, 2020 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-32278004
15.
Global Perspectives on Nonalcoholic Fatty Liver Disease and Nonalcoholic Steatohepatitis.
Hepatology
; 69(6): 2672-2682, 2019 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-30179269
16.
Transient elastography for screening of liver fibrosis: Cost-effectiveness analysis from six prospective cohorts in Europe and Asia.
J Hepatol
; 71(6): 1141-1151, 2019 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-31470067
17.
Reduced Patient-Reported Outcome Scores Associate With Level of Fibrosis in Patients With Nonalcoholic Steatohepatitis.
Clin Gastroenterol Hepatol
; 17(12): 2552-2560.e10, 2019 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-30779990
18.
Fibrosis Severity as a Determinant of Cause-Specific Mortality in Patients With Advanced Nonalcoholic Fatty Liver Disease: A Multi-National Cohort Study.
Gastroenterology
; 155(2): 443-457.e17, 2018 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-29733831
19.
Impact of Obesity and Alanine Aminotransferase Levels on the Diagnostic Accuracy for Advanced Liver Fibrosis of Noninvasive Tools in Patients With Nonalcoholic Fatty Liver Disease.
Am J Gastroenterol
; 114(6): 916-928, 2019 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-31169533
20.
Patients With Nonalcoholic Steatohepatitis Experience Severe Impairment of Health-Related Quality of Life.
Am J Gastroenterol
; 114(10): 1636-1641, 2019 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-31464743